Dr. Reimar Schlingensiepen
Studied medicine in Oxford, Paris and Göttingen. Doctorate at Max-Planck Institute for Biophysical Chemistry in Göttingen. Doctor from 1991 in oncology in the conduct of clinical studies and consultant to the pharmaceutical industry for the manufacture and analysis of biotechnology products. 1998 founder and managing director of Antisense Pharma GmbH at the BioPark. Since 2008 interim manager and coach for biotech and medtech companies.